Skip to main content

Piccina Cintia

In the past year, 1 open-market sale filing worth $15.7K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$15.7K
1 filing
Net
−$15.7K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Piccina Cintia as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

AUTL Autolus Therapeutics plc

U.S. CCO & Country Gen Manager1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 3, 2026 (view filing)4:36 PM ETSep 21 dayPiccina CintiaU.S. CCO & Country Gen ManagerSSaleAmerican Depositary Shares−6.71K$2.34−$15.7K−33.6%13.3K after

ADAPY Adaptimmune Therapeutics PLC

Chief Commercial Officer4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 15, 2025 (view filing)Jan 15Same dayPiccina CintiaChief Commercial OfficerSSaleAmerican Depositary Shares representing Ordinary Shares−13.0K$0.57−$7.40K−41.4%18.4K after
Jun 18, 2024 (view filing)Jun 18Same dayPiccina CintiaChief Commercial OfficerSSaleAmerican Depositary Shares representing Ordinary Shares−24.5K$0.93−$22.8K−39.0%38.3K after
Jan 31, 2023 (view filing)Jan 31Same dayPiccina CintiaChief Commercial OfficerSSaleAmerican Depositary Shares representing Ordinary Shares−11.9K$1.87−$22.2K−37.8%19.5K after
Aug 1, 2022 (view filing)Aug 1Same dayPiccina CintiaChief Commercial OfficerSSaleAmerican Depositary Shares representing Ordinary Shares−21.0K$1.77−$37.2K−37.7%34.8K after